Companies: 10,795·Total market cap: $144.5T
BioNTech SE

BioNTech SE

BNTXNASDAQHealthcare● Active
$88.08
$-1.51(-1.69%)
Market Cap$22.3B
P/E Ratio—
52W High$124
52W Low$79.52
SEC Filings
Foreign Private Issuer · Files 20-F / 6-K

BioNTech SE (BNTX) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001776985 · BNTX · NASDAQ · as of Jun 8, 2026

Filing snapshot

549
Total Filings
6-K
Latest Form
2026-06-01
Most Recent
2019
Filing Since
FinancialsEarningsView All on EDGAR

Source: SEC EDGAR (data.sec.gov) · CIK 0001776985 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2026-03-10
Fiscal Year End
Mar 10, 2026
Accession No.
0001776985-26-000017
Primary Document
bntx-20251231.htm
View on SEC EDGARDownload PDFFiling Index
Source: data.sec.gov · CIK 0001776985 · Accession 0001776985-26-000017

Latest Key Filings

6-KQuarterly Report
6-K
2026-06-01
View 6-K on SEC
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

View Insider Trades Tab

SEC Filing History

Hide Form 4 / 144
6-KCurrent Report (Foreign Issuer)
6-K
2026-06-01
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-05-22
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-15
View
SCHEDULE 13G/ASCHEDULE 13G/A
SCHEDULE 13G/A
2026-05-14
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-05-07
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-05-05
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-05-05
View
3/AInitial Statement of Beneficial Ownership (Amended)
FORM 3/A
2026-04-13
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-04-13
View
6-KCurrent Report (Foreign Issuer)
6-K
2026-04-02
View
20-F/A20-F/A
20-F/A
2026-04-01
View
3Initial Statement of Beneficial Ownership
FORM 3
2026-03-25
View
3Initial Statement of Beneficial Ownership
FORM 3
2026-03-25
View
3Initial Statement of Beneficial Ownership
FORM 3
2026-03-25
View
Showing 1–15 of 490 filingsForm 4 / 144 hidden· 549 total in EDGAR

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001776985  |  Exchange: NASDAQ · Healthcare

BioNTech SE (NASDAQ: BNTX) has submitted 549 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2019. As a Healthcare sector company with CIK 0001776985, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is BioNTech SE's most comprehensive regulatory disclosure. The most recent BioNTech SE 10-K was filed on 2026-03-10 for fiscal year ending 2026. Historical BNTX 10-K annual reports are available from 2019 through 2026.

Investors researching BioNTech SE SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-08
Related Companies SEC Filings — Healthcare
TEVA SEC Filings →NTRA SEC Filings →BIIB SEC Filings →DXCM SEC Filings →PHG SEC Filings →RPRX SEC Filings →UTHR SEC Filings →STE SEC Filings →
→ BNTX Financials→ BNTX Earnings→ BNTX Insider Trades

Frequently Asked Questions

BNTX SEC Filings · 8 questions

BioNTech SE (BNTX) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 549 filings and access original documents at no cost. BioNTech SE's CIK is 0001776985.

BNTX SEC filingsBioNTech SE SEC documentsfind BNTX 10-K